Cell- and gene-specific regulation of primary target genes by the androgen receptor.
The androgen receptor (AR) mediates the physiologic and pathophysiologic effects of androgens including sexual differentiation, prostate development, and cancer progression by binding to genomic androgen response elements (AREs), which influence transcription of AR target genes. The composition and context of AREs differ between genes, thus enabling AR to confer multiple regulatory functions within a single nucleus. We used expression profiling of an immortalized human prostate epithelial cell line to identify 205 androgen-responsive genes (ARGs), most of them novel. In addition, we performed chromatin immunoprecipitation to identify 524 AR binding regions and validated in reporter assays the ARE activities of several such regions. Interestingly, 67% of our AREs resided within approximately 50 kb of the transcription start sites of 84% of our ARGs. Indeed, most ARGs were associated with two or more AREs, and ARGs were sometimes themselves linked in gene clusters containing up to 13 AREs and 12 ARGs. AREs appeared typically to be composite elements, containing AR binding sequences adjacent to binding motifs for other transcriptional regulators. Functionally, ARGs were commonly involved in prostate cell proliferation, communication, differentiation, and possibly cancer progression. Our results provide new insights into cell- and gene-specific mechanisms of transcriptional regulation of androgen-responsive gene networks.
Bolton
Eric C
EC
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California 94143, USA.
So
Alex Y
AY
Chaivorapol
Christina
C
Haqq
Christopher M
CM
Li
Hao
H
Yamamoto
Keith R
KR
D001483:Base Sequence; D001665:Binding Sites / Q000235:genetics; D002460:Cell Line; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D047369:Chromatin Immunoprecipitation; D004247:DNA / Q000235:genetics / Q000378:metabolism; D004847:Epithelial Cells / Q000378:metabolism; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D005810:Multigene Family; D011467:Prostate / Q000166:cytology / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D011944:Receptors, Androgen / Q000235:genetics* / Q000378:metabolism*
C410798:AR protein, human; D011944:Receptors, Androgen; D004247:DNA
Science. 1988 Apr 15;240(4850):324-6
3353726
Biochim Biophys Acta. 2003 Feb 20;1631(1):1-11
12573443
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1612-7
10677507
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10096-100
10944202
Mol Endocrinol. 1993 Jan;7(1):23-36
8446105
Science. 1992 Jul 17;257(5068):377-9
1631558
Exp Hematol. 2002 Jun;30(6):503-12
12063017
Mol Cell. 2002 Mar;9(3):601-10
11931767
Biochemistry. 1993 Jun 29;32(25):6459-64
7686046
Development. 1999 May;126(10):2033-44
10207129
Oncogene. 2004 Aug 12;23(36):6105-14
15208657
Oncogene. 2007 Jun 28;26(30):4453-63
17297473
J Biol Chem. 2005 Mar 4;280(9):8503-12
15611079
Cell. 2006 May 5;125(3):483-95
16603237
Mol Cell. 2005 Sep 2;19(5):631-42
16137620
Am J Pathol. 2001 Dec;159(6):2159-65
11733366
FEBS Lett. 2006 Oct 9;580(23):5442-9
16876788
Cancer Res. 2002 Aug 1;62(15):4499-506
12154061
Genome Biol. 2002 Jun 14;3(7):RESEARCH0032
12184806
Development. 2004 Aug;131(16):3931-42
15253934
J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):23-30
11384860
PLoS Genet. 2007 Jun;3(6):e94
17559307
Mol Cell Biol. 2004 May;24(9):3804-14
15082775
Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15603-8
15501915
J Endocrinol. 2001 Jul;170(1):287-96
11431162
Prostate. 1997 Dec 1;33(4):264-70
9397199
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14724-9
10611280
Nature. 2005 Sep 15;437(7057):436-9
16079795
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12247-52
14527995
Genome Biol. 2003;4(5):P3
12734009
Oncogene. 2006 Nov 16;25(54):7212-23
16732317
Endocrinology. 2006 Jan;147(1):590-8
16210365
Nature. 1998 Apr 30;392(6679):885-8
9582068
Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):811-6
14711987
Eur J Biochem. 1994 Jan 15;219(1-2):357-63
7508385
J Biol Chem. 1997 May 30;272(22):14087-92
9162033
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13845-50
14617768
J Biol Chem. 1997 Jul 11;272(28):17485-94
9211894
J Mol Endocrinol. 2004 Oct;33(2):477-91
15525603
Nucleic Acids Res. 2003 Jan 1;31(1):374-8
12520026
Nat Biotechnol. 2002 Aug;20(8):835-9
12101404
J Leukoc Biol. 2000 Jul;68(1):1-8
10914483
Cancer Res. 2006 Jul 15;66(14):6998-7006
16849544
Cell. 2005 Jul 15;122(1):33-43
16009131
Nature. 2005 Aug 11;436(7052):876-80
15988478
Mol Cell Endocrinol. 2000 Sep 25;167(1-2):139-50
11000528
Annu Rev Microbiol. 2003;57:419-40
14527286
Cell. 1988 Aug 26;54(5):659-64
3044607
Mol Cell Biol. 1988 Jun;8(6):2350-60
3165490
Curr Opin Lipidol. 2001 Jun;12(3):289-96
11353332
Genes Dev. 2002 Jan 15;16(2):235-44
11799066
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11890-5
12185249
PLoS Genet. 2005 Aug;1(2):e16
16110340
Urology. 2006 Jan;67(1):204-8
16413376
Am J Physiol Endocrinol Metab. 2002 Nov;283(5):E971-9
12376324
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2244-9
11226224
J Biol Chem. 1996 Mar 15;271(11):6379-88
8626436
Mol Endocrinol. 2005 May;19(5):1200-12
15650026
Science. 1988 Apr 15;240(4850):327-30
3353727
J Lipid Res. 1999 Apr;40(4):672-9
10191291